Article
Identification of novel GRM1 mutations and single nucleotide polymorphisms in prostate cancer cell lines and tissues.
PloS one - 1 Jan 2014
Ali Shafat, Shourideh Mojgan, Koochekpour Shahriar
Abstract excerpt
Metabotropic glutamate receptor 1 (GRM1) signaling has been implicated in benign and malignant disorders including prostate cancer (PCa). To further explore the role of genetic alterations of GRM1 in PCa, we screened the entire human GRM1 gene including coding sequence, exon-intron junctions, and flanking untranslated regions (UTRs) for the presence of mutations and single nucleotide polymorphisms (SNPs) in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
